On December 2, 2024, Zhejiang Kinso Technology Co., Ltd. (hereinafter referred to as "Kinsotech") welcomed distinguished guests from India for an in-depth visit and exchange aimed at exploring future cooperation and development opportunities in the field of pharmaceutical intermediates. Senior management warmly received the visitors and accompanied them on a tour of the company's laboratory, pilot workshop, and R&D center, providing firsthand experience of Kinsotech's robust R&D capabilities and significant growth potential.
The Indian delegation first toured Kinsotech's state-of-the-art laboratory, where they gained insights into the company's research and development processes, scientific research team, technical expertise, and various patents and accolades. The advanced instrumentation and rigorous R&D protocols left a lasting impression on the visitors.
Next, the group proceeded to the pilot workshop, where experimenters were conducting trials on new products. The Indian delegates observed the operational procedures closely, inquiring about the production process and quality control measures for compounds such as 4-bromo-2-fluoroaniline (CAS: 367-24-8). They expressed high praise for the meticulousness and efficiency demonstrated.
At the R&D center, Kinsotech's technical team presented the latest R&D projects to the Indian visitors, detailing their application prospects in the pharmaceutical intermediates sector. The Indian delegates expressed admiration for Kinsotech's innovative spirit and believed that collaboration with Kinsotech would unlock boundless possibilities for mutual growth in this field.
Following the tour, both parties held an in-depth exchange meeting. Kinsotech executives outlined the company's strategic development plans and market positioning, emphasizing their strong desire to enhance cooperation with Indian partners in the pharmaceutical intermediates domain. The Indian visitors shared valuable insights into the Indian market and expressed optimism about future collaborations. Both sides agreed on extensive cooperation potential in areas such as product R&D, market expansion, and technical exchanges, aiming to jointly promote innovation and development in the pharmaceutical intermediates industry.
This visit not only deepened mutual understanding and trust but also laid a solid foundation for Kinsotech's further exploration of international markets. Kinsotech will seize this opportunity to uphold its business philosophy of "Survival by quality, Develop by innovation, Win-win by integrity" continuously enhancing its capabilities to provide global customers with high-quality and efficient pharmaceutical intermediates products and services, and co-create a new chapter of cooperative development.
